He Meilin, Yi Junlin
Department of Radiation Oncology National Cancer Center/ National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College，Beijing，100021，China.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 Sep;37(9):734-739. doi: 10.13201/j.issn.2096-7993.2023.09.009.
Oropharyngeal carcinoma is one of the most common malignant tumors of head and neck. In recent years, the incidence of Human papilloma virus-associated oropharyngeal squamous cell carcinoma（HPV-OPSCC） has been increasing year by year. With the advancement of minimally invasive surgical techniques, the wide application of intensity modulated radiation therapy, and the demand of patients for organ function protection and higher quality of life, the unique biological behavior and better prognosis of HPV-OPSCC have led to the exploration of a series of attenuated treatment modes. This article reviews the diagnosis and treatment status of oropharyngeal cancer and related research progress based on relevant reports.
口咽癌是头颈部最常见的恶性肿瘤之一。近年来，人乳头瘤病毒相关的口咽鳞状细胞癌（HPV-OPSCC）的发病率逐年上升。随着微创外科技术的进步、调强放射治疗的广泛应用以及患者对器官功能保护和更高生活质量的需求，HPV-OPSCC独特的生物学行为和较好的预后促使人们探索一系列减量化的治疗模式。本文基于相关报道对口咽癌的诊治现状及相关研究进展进行综述。
